Project Details
Description
A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physicians Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent
| Status | Finished |
|---|---|
| Effective start/end date | 12/31/15 → 7/1/21 |
Funding
- ONCONOVA THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.